Follow
Alison Ritter
Alison Ritter
Drug Policy Modelling Program, UNSW Australia
Verified email at unsw.edu.au
Title
Cited by
Cited by
Year
A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs
A Ritter, J Cameron
Drug and alcohol review 25 (6), 611-624, 2006
4092006
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS)
J Ross, M Teesson, S Darke, M Lynskey, R Ali, A Ritter, R Cooke
Drug and alcohol review 24 (5), 411-418, 2005
3032005
How do drug policy makers access research evidence?
A Ritter
International Journal of Drug Policy 20 (1), 70-75, 2009
2012009
One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS)
M Teesson, J Ross, S Darke, M Lynskey, R Ali, A Ritter, R Cooke
Drug and alcohol dependence 83 (2), 174-180, 2006
1782006
Producing the ‘problem of drugs’: A cross national-comparison of ‘recovery’discourse in two Australian and British reports
K Lancaster, K Duke, A Ritter
International Journal of Drug Policy 26 (7), 617-625, 2015
1742015
The reliability and internal validity of the Wisconsin Card Sorting Test
SC Bowden, KS Fowler, RC Bell, G Whelan, CC Clifford, AJ Ritter, ...
Neuropsychological Rehabilitation 8 (3), 243-254, 1998
1441998
Studying illicit drug markets: Disciplinary contributions
A Ritter
International Journal of Drug Policy 17 (6), 453-463, 2006
1402006
Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985–2010
K Lancaster, A Ritter
International Journal of Drug Policy 25 (1), 81-87, 2014
1352014
Serious adverse events in the Australian national evaluation of pharmacotherapies for opioid dependence (NEPOD)
E Digiusto, A Shakeshaft, A Ritter, S O'Brien, RP Mattick, ...
Addiction 99 (4), 450-460, 2004
1262004
LAAM maintenance vs methadone maintenance for heroin dependence
NC Clark, N Lintzeris, A Gijsbers, G Whelan, A Dunlop, A Ritter, WW Ling, ...
Cochrane Database of Systematic Reviews 2010 (1), 1996
1261996
Take-home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine
J Strang, R McDonald, G Campbell, L Degenhardt, S Nielsen, A Ritter, ...
Drugs 79, 1395-1418, 2019
1052019
Pill testing or drug checking in Australia: acceptability of service design features
MJ Barratt, R Bruno, N Ezard, A Ritter
Drug and alcohol review 37 (2), 226-236, 2018
1052018
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting
AH Harris, E Gospodarevskaya, AJ Ritter
Pharmacoeconomics 23, 77-91, 2005
1052005
The ethics of paying drug users who participate in research: A review and practical recommendations
CL Fry, W Hall, A Ritter, R Jenkinson
Journal of Empirical Research on Human Research Ethics 1 (4), 21-35, 2006
1042006
Global review of drug checking services operating in 2017
MJ Barratt, M Kowalski, LJ Maier, A Ritter
Drug policy modelling program bulletin 24, 1-23, 2018
1022018
Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose
AJ Ritter
Australian & New Zealand Journal of Psychiatry 36 (2), 224-228, 2002
1002002
Paying research participants: a study of current practices in Australia
CL Fry, A Ritter, S Baldwin, KJ Bowen, P Gardiner, T Holt, R Jenkinson, ...
Journal of medical ethics 31 (9), 542-547, 2005
982005
The influence of the therapeutic relationship in treatment for alcohol dependency
A Ritter, S Bowden, T Murray, P Ross, J Greeley, J Pead
Drug and alcohol review 21 (3), 261-268, 2002
942002
The productive techniques and constitutive effects of ‘evidence-based policy’and ‘consumer participation’discourses in health policy processes
K Lancaster, K Seear, C Treloar, A Ritter
Social Science & Medicine 176, 60-68, 2017
932017
The deterrent effects of Australian street-level drug law enforcement on illicit drug offending at outdoor music festivals
CE Hughes, V Moxham-Hall, A Ritter, D Weatherburn, R MacCoun
International Journal of Drug Policy 41, 91-100, 2017
922017
The system can't perform the operation now. Try again later.
Articles 1–20